Perrigo Company PLC Stock TEL AVIV STOCK EXCHANGE
Stocks
IE00BGH1M568
Pharmaceuticals
| Market Cap | 1.78B 0 1.55B 1.45B 1.32B 2.48B 170B 2.53B 16.96B 6.65B 85.13B 6.7B 6.55B 284B | P/E 2026 * |
-8.03x | P/E 2027 * | -31.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.69B 0 4.06B 3.8B 3.47B 6.53B 447B 6.64B 44.59B 17.47B 224B 17.6B 17.22B 747B | EV / Sales 2026 * |
1.15x | EV / Sales 2027 * | 1.12x |
| Free-Float |
99.6% | Yield 2026 * |
9% | Yield 2027 * | 9.23% |
Last Transcript: Perrigo Company PLC
| 1 day | -1.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Manzone
CEO | Chief Executive Officer | 63 | 2026-06-06 |
Eduardo Bezerra
DFI | Director of Finance/CFO | 51 | 2022-05-15 |
Matt Winterman
COO | Chief Operating Officer | - | 2025-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Donal O'Connor
BRD | Director/Board Member | 75 | 2014-10-31 |
Geoffrey Parker
BRD | Director/Board Member | 61 | 2016-11-06 |
Bradley Alford
BRD | Director/Board Member | 70 | 2017-02-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -0.80% | - | - | 1.75B | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,098B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 631B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 438B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 368B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 298B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 251B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 226B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 209B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 165B | |
| Average | -0.40% | +1,662.58% | +34.23% | +45.11% | 409.37B | |
| Weighted average by Cap. | -0.63% | +1,339.54% | +49.81% | +66.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.06B 0 3.52B 3.29B 3B 5.65B 387B 5.75B 38.62B 15.13B 194B 15.24B 14.91B 647B | 4.09B 0 3.54B 3.32B 3.03B 5.7B 390B 5.79B 38.9B 15.24B 195B 15.35B 15.02B 651B |
| Net income | -224M -0 -194M -182M -166M -312M -21.37B -317M -2.13B -835M -10.7B -841M -823M -35.69B | -56.95M -0 -49.35M -46.2M -42.16M -79.33M -5.43B -80.66M -542M -212M -2.72B -214M -209M -9.07B |
| Net Debt | 2.9B 0 2.52B 2.36B 2.15B 4.05B 277B 4.11B 27.63B 10.83B 139B 10.91B 10.67B 463B | 2.78B 0 2.41B 2.26B 2.06B 3.88B 266B 3.94B 26.48B 10.38B 133B 10.45B 10.22B 443B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
